Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2022	$ 214,442	$ 8	$ 798,696	$ (4,575)	$ (579,687)
Beginning balance (in shares) at Dec. 31, 2022		82,895,718
Exercise of stock options	1,079		1,079
Exercise of stock options (in shares)		132,191
Vesting of restricted stock units		323,869
Stock-based compensation	10,975		10,975
Unrealized loss on marketable securities	2,376			2,376
Net Income (Loss)	(45,857)				(45,857)
Ending balance at Mar. 31, 2023	183,015	$ 8	810,750	(2,199)	(625,544)
Ending balance (in shares) at Mar. 31, 2023		83,351,778
Beginning balance at Dec. 31, 2023	$ 134,158	$ 8	844,044	184	(710,078)
Beginning balance (in shares) at Dec. 31, 2023	84,879,693	84,879,693
Issuance of common stock upon public offering, net of issuance cost $3,892	$ 71,108	$ 1	71,107
Issuance of common stock upon public offering, net of issuance cost $3,892(in shares)		10,869,566
Vesting of restricted stock units		635,303
Stock-based compensation	10,307		10,307
Unrealized loss on marketable securities	(587)			(587)
Net Income (Loss)	(36,079)				(36,079)
Ending balance at Mar. 31, 2024	$ 178,907	$ 9	$ 925,458	$ (403)	$ (746,157)
Ending balance (in shares) at Mar. 31, 2024	96,384,562	96,384,562